Alector logo

Alector

ALEC | NASDAQ
Chart Builder DCF Calculator
$2.57
+$0.03 (+1.18%)
At close: Nov 16, 2026, 4:00 PM ET
$2.52
-$0.05 (-1.95%)
After-hours: Nov 16, 2026, 7:53 PM ET
+1.18%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
81.5
Fundamentals Excellent
Market Sentiment Bullish
Moat None
Sector Rank #14/1021 (Top 1%)

Key Statistics

Market Data

Market Cap $382.61M
1D Range
2.52 2.66
52W Range
1.14 2.72

Valuation (TTM)

PE 7.14
PB 3.28
EV/EBITDA 5.85

Valuation (NTM)

Forward PE 4.46
Forward PEG -0.05
Price Target $3.00
Loading financial charts...

Profile

Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally ...

Sector Healthcare
Industry Biotechnology
Employees 103
IPO Date Feb 7, 2019
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 5, 2026
EPS
$1.11
Beat +591.41%
REV
$162.87M
Beat +6743.11%
Next Earnings
Feb 24, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
4
Consensus
Buy
Price Target
$3.00
Upside
+16.73%
Buy (3)
Hold (0)
Sell (1)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.